Literature DB >> 2492694

A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis.

P Bedossa1, S Houry, J Bacci, E Martin, G Lemaigre, M Huguier.   

Abstract

A longitudinal study of intra and extrahepatic bile duct injuries was performed in an animal model of secondary sclerosing cholangitis induced by formalin injection into the common bile duct. Lymphocytic infiltration inside and around the bile ducts occurred seven days after injection. The disease later evolved to a fibrous cholangitis of the small bile ducts. Septal intrahepatic and extrahepatic bile duct involvement became evident three months after formalin injection. The ductular proliferation led to a progressive biliary cirrhosis with portal to portal fibrous septa. After formalin injection, bile duct cells expressed the Ia antigen in the cytoplasm and/or on the membrane of bile duct cells. The intensity of staining did not correlate with the duration or severity of the disease. Lymphocytes infiltrating into and around the bile duct were mainly T-cells. This study suggests that a local cell-mediated immune response to the injection of a toxic agent induces pathological features similar to those of sclerosing cholangitis in man.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492694     DOI: 10.1007/bf00718596

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  27 in total

1.  PERICHOLANGITIS AND ULCERATIVE COLITIS. I. PATHOLOGY, ETIOLOGY, AND PATHOGENESIS.

Authors:  S P MISTILIS
Journal:  Ann Intern Med       Date:  1965-07       Impact factor: 25.391

2.  Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis.

Authors:  T L Whiteside; S Lasky; L Si; D H Van Thiel
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

3.  Primary sclerosing cholangitis.

Authors:  R W Chapman
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

4.  Elevated circulating immune complexes in primary sclerosing cholangitis.

Authors:  H C Bodenheimer; N F LaRusso; W R Thayer; C Charland; P J Staples; J Ludwig
Journal:  Hepatology       Date:  1983 Mar-Apr       Impact factor: 17.425

5.  Current concepts. Primary sclerosing cholangitis.

Authors:  N F LaRusso; R H Wiesner; J Ludwig; R L MacCarty
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

6.  Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.

Authors:  R W Chapman; P M Kelly; A Heryet; D P Jewell; K A Fleming
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

7.  Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

Authors:  T Hanafusa; R Pujol-Borrell; L Chiovato; R C Russell; D Doniach; G F Bottazzo
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

8.  Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; B C Portmann; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

9.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

10.  Cholangiographic abnormalities in ulcerative colitis associated pericholangitis which resemble sclerosing cholangitis.

Authors:  M O Blackstone; B A Nemchausky
Journal:  Am J Dig Dis       Date:  1978-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.